Prot# GL03-01: A Multi-Center, Open-Label Study to Assess the Durability and Safety of the Prevention of Bone Loss by Treatment with GL701 (Prestara?) in Women with Systemic Lupus Erythematosus Receiving Treatment with Glucocorticoids

Project: Research project

Project Details

StatusFinished
Effective start/end date9/22/0412/22/04

Funding

  • Genelabs Technologies, Inc. (GL03-01)